Oppenheimer & Co’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Oppenheimer & Co’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26,008	Closed	-$1.4M	–	1429
2017 Q4	$1.4M	Sell	26,008 -73	-0.3%	-$3.99K	0.04%	506
2017 Q3	$1.49M	Sell	26,081 -1,206	-4%	-$70.6K	0.04%	469
2017 Q2	$1.64M	Sell	27,287 -497	-2%	-$28.3K	0.05%	446
2017 Q1	$1.51M	Buy	+27,784	New	+$1.37M	0.04%	455

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Oppenheimer & Co's BIVV Position: Q1 2018 in Review

Oppenheimer & Co sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 26,008 shares — an estimated $1.4M sold.

Oppenheimer & Co first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.64M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Oppenheimer & Co reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Oppenheimer & Co sold 26,008 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.4M.
Oppenheimer & Co first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Oppenheimer & Co's Bioverativ Inc. Common Stock position peaked at $1.64M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Oppenheimer & Co's 13F filing for Q1 2018, filed 1 May 2018.